ATE395925T1 - Zytotoxische pharmazeutische zusammensetzung - Google Patents

Zytotoxische pharmazeutische zusammensetzung

Info

Publication number
ATE395925T1
ATE395925T1 AT03701291T AT03701291T ATE395925T1 AT E395925 T1 ATE395925 T1 AT E395925T1 AT 03701291 T AT03701291 T AT 03701291T AT 03701291 T AT03701291 T AT 03701291T AT E395925 T1 ATE395925 T1 AT E395925T1
Authority
AT
Austria
Prior art keywords
pharmaceutical composition
dose
cytotoxic pharmaceutical
diindolymethane
chrysin
Prior art date
Application number
AT03701291T
Other languages
German (de)
English (en)
Inventor
Michael D Farley
Original Assignee
Michael D Farley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael D Farley filed Critical Michael D Farley
Application granted granted Critical
Publication of ATE395925T1 publication Critical patent/ATE395925T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/82—Theaceae (Tea family), e.g. camellia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03701291T 2003-01-09 2003-01-09 Zytotoxische pharmazeutische zusammensetzung ATE395925T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2003/000709 WO2004062683A1 (en) 2003-01-09 2003-01-09 Improvements in or relating to immune functions

Publications (1)

Publication Number Publication Date
ATE395925T1 true ATE395925T1 (de) 2008-06-15

Family

ID=34885486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03701291T ATE395925T1 (de) 2003-01-09 2003-01-09 Zytotoxische pharmazeutische zusammensetzung

Country Status (7)

Country Link
EP (1) EP1581238B1 (enExample)
JP (1) JP2006501308A (enExample)
CN (1) CN100579535C (enExample)
AT (1) ATE395925T1 (enExample)
DE (1) DE60321227D1 (enExample)
MX (1) MXPA04011768A (enExample)
WO (1) WO2004062683A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8697670B2 (en) * 2009-01-28 2014-04-15 Life Science Nutrition As Compositions and methods of treating viral infections
ES2428665B1 (es) * 2012-05-04 2014-10-01 Universidad De Valladolid Composición para su uso en el tratamiento y/o prevención de la inflamación, el estrés oxidativo y la neovascularización ocular
CN106974904B (zh) * 2017-03-14 2020-07-28 南方医科大学 杨梅素及其衍生物的新用途和一种抗hiv感染的杀微生物剂
CN110772578A (zh) * 2019-11-11 2020-02-11 李胜 一种用于癌症防治的人体免疫力增强剂及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU689036B2 (en) * 1995-05-10 1998-03-19 Kureha Chemical Industry Co., Ltd. Pharmaceutical composition containing substance inhibiting HSP47 production
IL129034A (en) * 1996-09-20 2002-03-10 Howard Foundation Flavonol and anthocyanin containing food supplements
US6238673B1 (en) * 1996-09-20 2001-05-29 The Howard Foundation Method of producing high flavonol content polyphenol compositions
US6086915A (en) * 1998-04-01 2000-07-11 Bioresponse L.L.C. Compositions and methods of adjusting steroid hormone metabolism through phytochemicals
US20020192310A1 (en) * 2001-02-02 2002-12-19 Bland Jeffrey S. Medical composition for managing hormone balance

Also Published As

Publication number Publication date
DE60321227D1 (de) 2008-07-03
EP1581238B1 (en) 2008-05-21
CN100579535C (zh) 2010-01-13
MXPA04011768A (es) 2005-03-31
EP1581238A1 (en) 2005-10-05
HK1078471A1 (en) 2006-03-17
CN1638786A (zh) 2005-07-13
JP2006501308A (ja) 2006-01-12
WO2004062683A1 (en) 2004-07-29

Similar Documents

Publication Publication Date Title
US6544564B1 (en) Cytotoxic pharmaceutical composition
HUP0400882A2 (hu) Onkolitikus vírusterápia
WO2004112711A3 (en) Oral extended-release composition
UA103758C2 (ru) Конъюгаты олигомеров инсулина, их композиции и применение
HUP0401534A2 (hu) Módosított humán IX. faktor
BE2011C013I2 (enExample)
BR0015188A (pt) Composições farmacêuticas
SG167657A1 (en) Novel medicament compositions based on tiotropium salts and on salmeterol salts
UA91044C2 (uk) Жива послаблена ротавірусна вакцина для перорального застосування
US6767563B2 (en) Immune functions
PT1383752E (pt) 3-piperidinopropiofenonas deuteradas assim como farmacos contendo estes compostos
ATE499939T1 (de) Neue pharmazeutische zusammenstezungen, flibanserin polymorph a enthaltend
ZA200303037B (en) Herbal pharmaceutical composition for treatment of HIV/Aids patients.
AR035652A1 (es) Una composicion nutricional, util para combatir la infeccion en el tracto gastrointestinal causada por organismos tipo helicobacter, el uso de dicha composicion para la preparacion de medicamentos, o productos alimenticios y el procedimiento para preparar dicha composicion
PL367464A1 (en) Pharmaceutical composition comprising lumiracoxib
BR0112807A (pt) Derivados de indol e sua aplicação como medicamento
ATE395925T1 (de) Zytotoxische pharmazeutische zusammensetzung
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
MXPA04001912A (es) Aminobenzofenonas novedosas.
DK1212072T3 (da) Farmaceutisk præparat omfattende eukalyptus- og orangeolie
MD3121F1 (en) Method of viral hepatitis B prophylaxis
AU2003219101A8 (en) Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein
RU2003114949A (ru) Биологически активная добавка "костные травы" для профилактики и вспомогательной терапии заболеваний опорно-двигательного аппарата
HRP20040165A2 (en) Citalopram for the treatment of elevated blood pressure
AR018468A1 (es) Agente terapeutico antineoplasico de hexoxido de arsenido (as4o6) a partir de una sustancia quimica natural y su composicion farmaceutica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties